Microbot Medical Inc. (MBOT) stock
MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.98−0.05 (-4.98%)
Close on Nov 13, 2026Market cap $65.73MP/E –Yield –
Microbot Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Microbot Medical's ebitda for the twelve months ending Sep 30, 2026 was -$21.08M. For fiscal 2025 it was -$14.70M. The highest annual figure on record is $2.04M in fiscal 2015.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.70M | – |
| FY2024 | Dec 31, 2024 | -$11.53M | – |
| FY2023 | Dec 31, 2023 | -$9.75M | – |
| FY2022 | Dec 31, 2022 | -$13.18M | – |
| FY2021 | Dec 31, 2021 | -$11.28M | – |
| FY2020 | Dec 31, 2020 | -$9.02M | – |
| FY2019 | Dec 31, 2019 | -$7.16M | – |
| FY2018 | Dec 31, 2018 | -$7.19M | -452.3% |
| FY2015 | Dec 31, 2015 | $2.04M | – |
| FY2014 | Dec 31, 2014 | -$29.60M | – |
| FY2013 | Dec 31, 2013 | -$27.03M | – |
| FY2012 | Dec 31, 2012 | -$20.92M | – |
| FY2011 | Dec 31, 2011 | -$26.87M | – |
| FY2010 | Dec 31, 2010 | -$27.84M | – |
| FY2009 | Dec 31, 2009 | -$27.68M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$6.47M | – |
| Q2 FY2026 | Jun 30, 2026 | -$6.17M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.13M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.85M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.01M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.40M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.28M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.50M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.36M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.03M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.52M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.30M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.89M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.54M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.16M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.91M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.54M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.37M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.61M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.40M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.87M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.15M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.95M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.77M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.53M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.91M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.08M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.73M | – |
| Q3 FY2016 | Sep 30, 2016 | -$645.00K | – |
See a number that looks wrong?